These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 24601226)
1. Inhibition potential of UDP-glucuronosyltransferases (Ugts) 1A isoforms by the analogue of resveratrol, bakuchiol. Dong DG; Zhang Y; Zhang SL; Lv J; Guo EM; Fang ZZ; Cao YF Pharmazie; 2014 Jan; 69(1):60-3. PubMed ID: 24601226 [TBL] [Abstract][Full Text] [Related]
2. In vitro evidence for bakuchiol's influence towards drug metabolism through inhibition of UDP-glucuronosyltransferase (UGT) 2B7. Xu Y; Li P; Zhang X; Wang J; Gu D; Wang Y Afr Health Sci; 2014 Sep; 14(3):564-9. PubMed ID: 25352873 [TBL] [Abstract][Full Text] [Related]
3. Biotransformation of baicalin to baicalein significantly strengthens the inhibition potential towards UDP-glucuronosyltransferases (UGTs) isoforms. Teng Y; Nian H; Zhao H; Chen P; Wang G Pharmazie; 2013 Sep; 68(9):763-7. PubMed ID: 24147345 [TBL] [Abstract][Full Text] [Related]
4. Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation. Lu H; Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Li H; Liu Y; Fu X; Sun H Fitoterapia; 2013 Jan; 84():208-12. PubMed ID: 23237733 [TBL] [Abstract][Full Text] [Related]
5. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294 [TBL] [Abstract][Full Text] [Related]
6. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases. Uchaipichat V; Mackenzie PI; Elliot DJ; Miners JO Drug Metab Dispos; 2006 Mar; 34(3):449-56. PubMed ID: 16381668 [TBL] [Abstract][Full Text] [Related]
7. The inhibition of UDP-glucuronosyltransferases (UGTs) by tetraiodothyronine (T4) and triiodothyronine (T3). Chen DW; Du Z; Zhang CZ; Zhang WH; Cao YF; Sun HZ; Zhu ZT; Yang K; Liu YZ; Zhao ZW; Fu ZW; Gu WQ; Yu Y; Fang ZZ Xenobiotica; 2018 Mar; 48(3):250-257. PubMed ID: 28285550 [TBL] [Abstract][Full Text] [Related]
8. Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms. Qi JQ; Cao YF; Sun XY; Hong M; Fang ZZ; Meng DL; Sun DX Pharmazie; 2015 Apr; 70(4):239-43. PubMed ID: 26012253 [TBL] [Abstract][Full Text] [Related]
9. Inhibition potential of glimepiride (gli) towards important UDP-glucuronosyltransferase (UGT) isoforms in human liver. Fu JF; Ren QY; Zhang NY; Gao B; Tu YY; Fu GQ; Li DH; Zhang YS Pharmazie; 2012 Aug; 67(8):715-7. PubMed ID: 22957438 [TBL] [Abstract][Full Text] [Related]
10. Cabozantinib Carries the Risk of Drug-Drug Interactions Wang Z; Jiang L; Wang X; Yin H; Wang Z; Lv X; Liu Y Curr Drug Metab; 2022; 23(11):912-919. PubMed ID: 36306450 [TBL] [Abstract][Full Text] [Related]
11. Enantioselective inhibition of carprofen towards UDP-glucuronosyltransferase (UGT) 2B7. Fang ZZ; Wang H; Cao YF; Sun DX; Wang LX; Hong M; Huang T; Chen JX; Zeng J Chirality; 2015 Mar; 27(3):189-93. PubMed ID: 25502512 [TBL] [Abstract][Full Text] [Related]
12. Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs). Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Ge GB; Liu Y; Zhang YY; Yang L; Sun HZ Toxicol Appl Pharmacol; 2013 Mar; 267(2):149-54. PubMed ID: 23306165 [TBL] [Abstract][Full Text] [Related]
13. Tacrolimus strongly inhibits multiple human UDP-glucuronosyltransferase (UGT) isoforms. Liu XY; Fang ZZ; Dong PP; Shi XH; Teng YJ; Sun XY Pharmazie; 2012 Sep; 67(9):804-8. PubMed ID: 23016456 [TBL] [Abstract][Full Text] [Related]
14. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro. Malfatti MA; Felton JS Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245 [TBL] [Abstract][Full Text] [Related]
15. Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases. Lv X; Zhang JB; Wang XX; Hu WZ; Shi YS; Liu SW; Hao DC; Zhang WD; Ge GB; Hou J; Yang L Chem Biol Interact; 2018 Mar; 284():48-55. PubMed ID: 29470958 [TBL] [Abstract][Full Text] [Related]
16. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4. Aprile S; Del Grosso E; Grosa G Drug Metab Dispos; 2010 Jul; 38(7):1141-6. PubMed ID: 20375181 [TBL] [Abstract][Full Text] [Related]
17. Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition Potential. Jia L; Hu C; Wang H; Liu Y; Liu X; Zhang YY; Li W; Wang LX; Cao YF; Fang ZZ Chirality; 2015 Jun; 27(6):359-63. PubMed ID: 25903196 [TBL] [Abstract][Full Text] [Related]
18. Everolimus-inhibited multiple isoforms of UDP-glucuronosyltransferases (UGTs). Du Z; Wang G; Cao YF; Hu CM; Yang K; Liu YZ; Zhang CZ; Zhang WH; Zhu ZT; Sun HZ; Sun XY; Hong M; Fang ZZ Xenobiotica; 2018 May; 48(5):452-458. PubMed ID: 28548030 [TBL] [Abstract][Full Text] [Related]
19. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine. Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liver. Huang T; Fang ZZ; Zhang YY; Zhu LL; Feng LL; Zheng W; Cao YF; Sun DX; Yang L Pharmazie; 2011 Mar; 66(3):212-5. PubMed ID: 21553653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]